Sponsor pipeline

Bavarian Nordic clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 2		3
Phase 3		3

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT07467707	An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of…	Chikungunya Virus	Recruiting	2026-06-29
NCT07003984	A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.	Chikungunya Virus	Active, Not Recruiting	2026-09-30
NCT06007183	Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or…	Chikungunya Virus Infection	Active, Not Recruiting	2026-08-07
Phase 2
NCT07199569	Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells	Monkeypox (Mpox)	Active, Not Recruiting	2026-04-08
NCT06549530	Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children…	Monkeypox (Mpox)	Active, Not Recruiting	2025-11-24
NCT06899802	A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine	Encephalitis	Active, Not Recruiting	2025-10-01

Get alerts when Bavarian Nordic's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.